Pancancer transcriptomic analysis revealed that higher expression of the TIM4+ TAM signature located in the tumor nest was associated with significantly worse disease-free survival (DFS) and overall survival (OS), whereas higher expression of the TIM4+ TAM signature in tertiary lymphoid structures predicted significantly better DFS [60]. The gene discussed is TIMD4; the disease is neoplasm.